Biogen マネジメント
マネジメント 基準チェック /44
現在、CEO に関する十分な情報がありません。
主要情報
Chris Viehbacher
最高経営責任者
US$4.1m
報酬総額
| CEO給与比率 | 39.3% |
| CEO在任期間 | 2yrs |
| CEOの所有権 | 0.005% |
| 経営陣の平均在職期間 | 4.5yrs |
| 取締役会の平均在任期間 | 4.4yrs |
経営陣の近況
Recent updates
Biogen Q3 Earnings Review: Why I Remain Optimistic Despite Difficult Quarter
Oct 31Does Biogen (NASDAQ:BIIB) Have A Healthy Balance Sheet?
Oct 01
What You Can Learn From Biogen Inc.'s (NASDAQ:BIIB) P/E
Sep 04Biogen: Q2 Earnings, Share Price May Have Bottomed Out As CEO Makes Mark
Aug 17Biogen Stock: Cheapish, But With Few Growth Prospects
Jul 11Is Biogen (NASDAQ:BIIB) Using Too Much Debt?
May 23Biogen's Revenue Dip Meets Cost Cuts In Q1 (Rating Upgrade)
Apr 29Earnings Update: Biogen Inc. (NASDAQ:BIIB) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
Apr 28The Price Is Right For Biogen Inc. (NASDAQ:BIIB)
Apr 15We Think You Can Look Beyond Biogen's (NASDAQ:BIIB) Lackluster Earnings
Feb 21Biogen Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Feb 16Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade)
Feb 14Here's Why Biogen (NASDAQ:BIIB) Can Manage Its Debt Responsibly
Jan 31Biotech And Pharma Diversification Pays Off
Jan 25Getting In Cheap On Biogen Inc. (NASDAQ:BIIB) Might Be Difficult
Dec 26An Intrinsic Calculation For Biogen Inc. (NASDAQ:BIIB) Suggests It's 49% Undervalued
Oct 21Is Biogen (NASDAQ:BIIB) Using Too Much Debt?
Oct 03Is Biogen Inc. (NASDAQ:BIIB) Trading At A 31% Discount?
Jul 16CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$2b |
| Jun 30 2024 | n/a | n/a | US$1b |
| Mar 31 2024 | n/a | n/a | US$1b |
| Dec 31 2023 | US$4m | US$2m | US$1b |
| Sep 30 2023 | n/a | n/a | US$1b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$3b |
| Dec 31 2022 | US$30m | US$154k | US$3b |
報酬と市場: Chrisの 総報酬 ($USD 4.07M ) は、 US市場 ($USD 12.66M ) の同様の規模の企業の平均を下回っています。
報酬と収益: Chrisの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Chris Viehbacher (63 yo)
2yrs
在職期間
US$4,069,913
報酬
Mr. Christopher A. Viehbacher, also known as Chris, is Director of Innocoll Holdings plc from July 24, 2017. He joined the Innocoll Holdings plc on July 24, 2017. He serves as President, Chief Executive Of...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 2yrs | US$4.07m | 0.0048% $ 1.1m | |
| Executive VP & CFO | 4.3yrs | US$7.17m | 0.013% $ 3.1m | |
| Head of Pharmaceutical Operations & Technology | 2.8yrs | US$5.71m | 0.0066% $ 1.5m | |
| Executive VP & Chief Legal Officer | 18.8yrs | US$6.70m | 0.035% $ 8.2m | |
| Head of Global Product Strategy & Commercialization | 3.8yrs | US$5.45m | 0.0067% $ 1.5m | |
| Senior VP & Chief Accounting Officer | 6yrs | データなし | 0.0043% $ 982.5k | |
| Head of Investor Relations | less than a year | データなし | データなし | |
| Chief Communication Officer & Head of Corporate Affairs | 4.8yrs | データなし | データなし | |
| Executive VP & Head of Corporate Development | 1.6yrs | データなし | 0.00045% $ 103.5k | |
| Executive VP & Chief Human Resources Officer | 7.3yrs | US$5.08m | 0.0093% $ 2.1m | |
| President & Head of North America | 7.3yrs | データなし | データなし | |
| Head of Biotherapeutics & Medicinal Sciences | 7.3yrs | データなし | データなし |
4.5yrs
平均在職期間
58yo
平均年齢
経験豊富な経営陣: BIIBの経営陣は 経験豊富 であると考えられます ( 4.5年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 2yrs | US$4.07m | 0.0048% $ 1.1m | |
| Independent Director | 14.7yrs | US$435.32k | 0.013% $ 3.0m | |
| Independent Director | 5.4yrs | US$425.73k | 0.0044% $ 1.0m | |
| Independent Chair of the Board | 14.8yrs | US$646.13k | 0.017% $ 3.9m | |
| Independent Director | 14.7yrs | US$418.02k | 0.014% $ 3.3m | |
| Independent Director | 3.4yrs | US$412.90k | 0.0031% $ 701.8k | |
| Directors | less than a year | データなし | データなし | |
| Independent Director | less than a year | データなし | 0.00092% $ 211.7k | |
| Independent Director | 5.4yrs | US$433.23k | 0.0051% $ 1.2m | |
| Independent Director | 1.4yrs | US$334.53k | 0.0019% $ 434.9k |
4.4yrs
平均在職期間
65yo
平均年齢
経験豊富なボード: BIIBの 取締役会 は 経験豊富 であると考えられます ( 4.4年の平均在任期間)。